USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Arçelik Anonim Sirketi

USPTO PatentsView assignee record - 24 granted patents across 0 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Arçelik ranks #12,356 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 0 technology areas.

#12,356
of 49,997 US assignees by volume
4th percentile
by Innovation Score (17.1/100)
1.0
avg claims per patent
+67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12356 · Foreign Corporation #12,356 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-RICH

  • GRANTS-SMALL 24 grants
  • UPPER-Q #12,356/49,997
  • PHOTO-FINISH Archem
  • CPC-UNK CPC blank
  • INNOV-LOW 17.1/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +67% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Archem Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arçelik’s 17.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Arçelik

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Arçelik's Innovation Score is 17.1/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Arçelik?

Each dot is one of Arçelik’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arçelik’s own 1.0 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Arçelik vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 0510152025 Granted patents (volume) Avg claims / patent ArQule Inc. - 24, 18.62ArquleArchem Inc. - 24, 9.88ArchemArchroma IP GmbH - 24, 19.04Archroma IPArkade, Inc. - 24, 15ArkadeAsahi Kasei Pharma Corporation - 24, 17.5Asahi Kasei PharmaAstera Labs, Inc. - 24, 20.12Astera LabsAstura Medical Inc. - 24, 15.71Astura MedicalAvantama AG - 24, 18.71AvantamaArçelik Anonim Sirketi - 24, 1Arçelik Anonim Si…
Arçelik vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arçelik's grants concentrate

Arçelik Anonim Sirketi is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2017. By volume, Arçelik sits between ArQule Inc. and Avantama AG.

Arçelik's three-year grant acceleration

Arçelik Anonim Sirketi shows 8 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Arçelik's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arçelik holds 24 patents at rank #12,359, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arçelik

By rank, the assignees closest to #12,359 in granted patent volume.

Arçelik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

17 4th percentile higher than 4% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20172018201920202021202220232024 3
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Arçelik Anonim Sirketi patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 4.2%
2018 5 20.8%
2019 3 12.5%
2020 4 16.7%
2021 3 12.5%
2022 3 12.5%
2023 2 8.3%
2024 3 12.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Arçelik Anonim Sirketi's patent record in context - here's where to go next.

  • Ranked #12,356 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Arçelik Anonim Sirketi against ArQule Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 17.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.